Bio-Rad Laboratories reports Q4 2023 net sales decline amidst biotech challenges. Full-year 2023 net sales also show a decrease. However, the company remains hopeful for future recovery with focus on cost improvement, potential growth in Digital PCR and process chromatography. Analyst comments indicate challenges need to be addressed for sustained growth.